Clinical Management of Check for Glomerular Diseases

被引:2
|
作者
Orr, Patty [1 ]
Shank, Bettina Cobb [1 ]
Hickson, Shondell [1 ]
Cooke, Jennifer [1 ]
机构
[1] Austin Peay State Univ, Sch Nursing, POB 4658, Clarksville, TN 37044 USA
关键词
Glomerulosclerosis; Focal segmental glomerulosclerosis; Diabetic nephropathy; Membranous nephropathy; Nephrotic syndrome; MEMBRANOUS NEPHROPATHY; RISK;
D O I
10.1016/j.cnur.2018.07.006
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Progressive glomerular damage can occur as a result of various etiologic factors including infections, medications, diseases, and autoimmune disorders. This article discusses the clinical management of the leading conditions associated with glomerular disease, including glomerulosclerosis, diabetic nephropathy, focal segmental glomerulosclerosis, and membranous nephropathy. Glomerular damage and disease progression may lead to end stage renal disease. Clinical management is individualized, as based on causative factors and clinical manifestations, with the overall goal of limiting glomerular damage. Collaborative and comprehensive care is imperative to improving patient outcomes.
引用
收藏
页码:551 / +
页数:18
相关论文
共 50 条
  • [1] KDIGO 2021 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF GLOMERULAR DISEASES
    Rovin, Brad H.
    Adler, Sharon G.
    Barratt, Jonathan
    Bridoux, Frank
    Burdge, Kelly A.
    Chan, Tak Mao
    Cook, H. Terence
    Fervenza, Fernando C.
    Gibson, Keisha L.
    Glassock, Richard J.
    Jayne, David R. W.
    Jha, Vivekanand
    Liew, Adrian
    Liu, Zhi-Hong
    Mejia-Vilet, Juan M.
    Nester, Carla M.
    Radhakrishnan, Jai
    Rave, Elizabeth M.
    Reich, Heather N.
    Ronco, Pierre
    Sanders, Jan-Stephan F.
    Sethi, Sanjeev
    Suzuki, Yusuke
    Tang, Sydney C. W.
    Tesar, Vladimir
    Vivarelli, Marina
    Wetzels, Jack F. M.
    Lytvyn, Lyubov
    Craig, Jonathan C.
    Tunnicliffe, David J.
    Howell, Martin
    Tonelli, Marcello A.
    Cheung, Michael
    Earley, Amy
    Floege, Juergen
    KIDNEY INTERNATIONAL, 2021, 100 (04) : S1 - S276
  • [2] Glomerular diseases in pregnancy: pragmatic recommendations for clinical management
    Fakhouri, Fadi
    Schwotzer, Nora
    Cabiddu, Gianfranca
    Barratt, Jonathan
    Legardeur, Helene
    Garovic, Vesna
    Orozco-Guillen, Alejandra
    Wetzels, Jack
    Daugas, Eric
    Moroni, Gabriella
    Noris, Marina
    Audard, Vincent
    Praga, Manuel
    Llurba, Elisa
    Wuerzner, Gregoire
    Attini, Rossella
    Desseauve, David
    Zakharova, Elena
    Luders, Claudio
    Wiles, Kate
    Leone, Filomena
    Jesudason, Shilpanjali
    Costedoat-Chalumeau, Nathalie
    Kattah, Andrea
    Soto-Abraham, Virgilia
    Karras, Alexandre
    Prakash, Jai
    Lightstone, Liz
    Ronco, Pierre
    Ponticelli, Claudio
    Appel, Gerald
    Remuzzi, Giuseppe
    Tsatsaris, Vassilis
    Piccoli, Giorgina Barbara
    KIDNEY INTERNATIONAL, 2023, 103 (02) : 264 - 281
  • [3] Treatment of glomerular diseases: pioneering clinical trials
    Radhakrishnan, Jai
    KIDNEY INTERNATIONAL, 2020, 97 (03) : 433 - 436
  • [4] Glomerular Diseases: Registries and Clinical Trials
    Moxey-Mims, Marva M.
    Flessner, Michael F.
    Holzman, Lawrence
    Kaskel, Frederick
    Sedor, John R.
    Smoyer, William E.
    Thompson, Aliza M.
    Yao, Lynne
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (12): : 2234 - 2243
  • [5] Paraneoplastic Glomerular Diseases
    Jeyabalan, Anushya
    Trivedi, Mayuri
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2022, 29 (02) : 116 - +
  • [6] Obinutuzumab for the management of immune-mediated glomerular diseases
    Rossi, Giovanni M.
    Baier, Eva
    Vaglio, Augusto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025,
  • [7] Paraneoplastic glomerular diseases and malignancies
    Bacchetta, Justine
    Juillard, Laurent
    Cochat, Pierre
    Droz, Jean-Pierre
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 70 (01) : 39 - 58
  • [8] Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
    Rovin, Brad H.
    Adler, Sharon G.
    Barratt, Jonathan
    Bridoux, Frank
    Burdge, Kelly A.
    Chan, Tak Mao
    Cook, H. Terence
    Fervenza, Fernando C.
    Gibson, Keisha L.
    Glassock, Richard J.
    Jayne, David R. W.
    Jha, Vivekanand
    Liew, Adrian
    Liu, Zhi-Hong
    Mejia-Vilet, Juan M.
    Nester, Carla M.
    Radhakrishnan, Jai
    Rave, Elizabeth M.
    Reich, Heather N.
    Ronco, Pierre
    Sanders, Jan-Stephan F.
    Sethi, Sanjeev
    Suzuki, Yusuke
    Tang, Sydney C. W.
    Tesar, Vladimir
    Vivarelli, Marina
    Wetzels, Jack F. M.
    Lytvyn, Lyubov
    Craig, Jonathan C.
    Tunnicliffe, David J.
    Howell, Martin
    Tonelli, Marcello A.
    Cheung, Michael
    Earley, Amy
    Floege, Jurgen
    KIDNEY INTERNATIONAL, 2021, 100 (04) : 753 - 779
  • [9] Drug-induced glomerular diseases
    Garnier, Anne-Sophie
    Laubacher, Helene
    Briet, Marie
    THERAPIE, 2024, 79 (02): : 271 - 281
  • [10] Complement Activation in Nephrotic Glomerular Diseases
    Nell, Dominik
    Wolf, Robert
    Podgorny, Przemyslaw Marek
    Kuschnereit, Tobias
    Kuschnereit, Rieke
    Dabers, Thomas
    Stracke, Sylvia
    Schmidt, Tilman
    BIOMEDICINES, 2024, 12 (02)